The emerging era of pharmacogenomics: current successes, future potential, and challenges
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The emerging era of pharmacogenomics: current successes, future potential, and challenges
Authors
Keywords
-
Journal
CLINICAL GENETICS
Volume 86, Issue 1, Pages 21-28
Publisher
Wiley
Online
2014-03-29
DOI
10.1111/cge.12392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Precision genome engineering
- (2014) Dana Carroll CURRENT BIOLOGY
- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- VKORC1andCYP2C9genotypes are predictors of warfarin-related outcomes in children
- (2014) Kaitlyn Shaw et al. PEDIATRIC BLOOD & CANCER
- Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity
- (2013) B C Carleton et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
- (2013) K Pussegoda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers
- (2012) J Sistonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
- (2012) Lieven Thorrez et al. CURRENT PHARMACEUTICAL DESIGN
- Genetic and Clinical Determinants Influencing Warfarin Dosing in Children With Heart Disease
- (2012) Nguyenvu Nguyen et al. PEDIATRIC CARDIOLOGY
- More Codeine Fatalities After Tonsillectomy in North American Children
- (2012) L. E. Kelly et al. PEDIATRICS
- Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation
- (2012) Frank S Ong et al. PHARMACOGENOMICS
- Pharmacogenetics at 50: Genomic Personalization Comes of Age
- (2012) T. J. Urban et al. Science Translational Medicine
- VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
- (2011) T. T. Biss et al. BLOOD
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population
- (2011) Cecilie Johannessen Landmark et al. EPILEPSY RESEARCH
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics of cisplatin-induced ototoxicity
- (2011) Debashree Mukherjea et al. PHARMACOGENOMICS
- Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
- (2011) Donna A. Volpe et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium
- (2009) Bruce M. Psaty et al. Circulation-Cardiovascular Genetics
- Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
- (2009) Sindhu Ramchandren et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
- (2009) Vladan Rajić et al. LEUKEMIA & LYMPHOMA
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
- (2009) Catherine Ciszkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
- (2009) Johanna Sistonen et al. Pharmacogenetics and Genomics
- Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers
- (2009) Jörn Lötsch et al. Pharmacogenetics and Genomics
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study
- (2008) P Madadi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antiepileptic drug utilization in children from 1997–2005—a study from the Netherlands
- (2008) N. W. van de Vrie-Hoekstra et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started